Phase 2 Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1 Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma.
Lee S, Hamid O, Jotte R, Zakharia Y, Medina T, Gillespie-Twardy A, Mehmi I, Chandra S, Watson G, Ward P, Chaney M, Lu H, Berndt J, O'Connor BP, Rathi K, Shaikh E, Cowey CL.
Lee S, et al. Among authors: lu h.
Clin Cancer Res. 2024 Dec 30. doi: 10.1158/1078-0432.CCR-24-1478. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 39786430